Inventor
FERNANDEZ-GADEA FRANCISCO JAVI
ES15 patents
⚠️ This page may combine multiple inventors who share the name “FERNANDEZ-GADEA FRANCISCO JAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
12 patentsUS5994376ANov 30, 1999
1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases
JANSSEN PHARMACEUTICA NV17 citations83
US7081453B2Jul 25, 2006
Compounds for treating impaired fundic relaxation
JANSSEN PHARMACEUTICA NV6 citations72
US6051718AApr 18, 2000
PDE IV inhibiting 2-cyanoiminoimidazole derivatives
JANSSEN PHARMACEUTICA NV15 citations71
US5952510ASep 14, 1999
1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity
JANSSEN PHARMACEUTICA NV3 citations61
US5869515AFeb 9, 1999
1,3-dihydro-2H-imidazol-2-one compounds
JANSSEN PHARMACEUTICA NV5 citations61
US6057441AMay 2, 2000
Substituted tetracyclic tetrahydrofuran derivatives
JANSSEN PHARMACEUTICA NV3 citations60
US5990123ANov 23, 1999
Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
JANSSEN PHARMACEUTICA NV2 citations59
US7423048B2Sep 9, 2008
Compounds for treating fundic disaccomodation
JANSSEN PHARMACEUTICA NV0 citations51
US5552399ASep 3, 1996
Substituted tetracyclic azepine derivatives
JANSSEN PHARMACEUTICA NV1 citations48
US7282508B2Oct 16, 2007
Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
JANSSEN PHARMACEUTICA NV0 citations39
US6156747ADec 5, 2000
Isoxazolidine derivatives
JANSSEN PHARMACEUTICA NV0 citations35
US7390822B2Jun 24, 2008
Substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage
JANSSEN PHARMACEUTICA NV0 citations33